[go: up one dir, main page]
KEGG   DRUG: Dapagliflozin, metformin and saxagliptin
Entry
D11711            Mixture   Drug                                   
Name
Dapagliflozin, metformin and saxagliptin;
Qternmet xr (TN)
Component
Dapagliflozin propanediol [DR:D09763], Metformin hydrochloride [DR:D00944], Saxagliptin hydrate [DR:D09753]
Class
Antidiabetic agent
 DG02044  Hypoglycemic agent
  DG03228  Combination of metformin, DPP-4 inhibitor and SGLT2 inhibitor
Remark
ATC code: A10BD25
Efficacy
Antidiabetic
  Disease
Type 2 diabetes mellitus [DS:H00409]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A10 DRUGS USED IN DIABETES
   A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
    A10BD Combinations of oral blood glucose lowering drugs
     A10BD25 Metformin, saxagliptin and dapagliflozin
      D11711  Dapagliflozin, metformin and saxagliptin
USP drug classification [BR:br08302]
 Blood Glucose Regulators
  Antidiabetic Combinations
   Dapagliflozin/ Metformin Hydrochloride/ Saxagliptin
    D11711  Dapagliflozin, metformin and saxagliptin
Drug groups [BR:br08330]
 Antidiabetic agent
  DG02044  Hypoglycemic agent
   DG03228  Combination of metformin, DPP-4 inhibitor and SGLT2 inhibitor
    D11711  Dapagliflozin, metformin and saxagliptin
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11711
Other DBs
PubChem: 405226577
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system